[The SPHA technic (solid phase hemadsorption) in syphilis serology. A year's experience in routine laboratory...

Syphilis diagnosis relies on detecting specific antibodies in patient sera. Established tests like VDRL and FTA-ABS have limitations in detecting IgM antibodies, especially in early or neurosyphilis cases. Prior research has shown that IgG can interfere with IgM detection in some assays. This gap motivated exploring alternative methods that avoid such interference. No prior work had resolved the issue of IgG-induced false negatives in IgM testing. Existing techniques require complex procedures and are difficult to automate. This paper's contribution is introducing a new method that eliminates IgG interference while maintaining high accuracy. The SPHA method offers a potential solution to a long-standing challenge in serological testing.

The aim was to evaluate the solid-phase hemadsorption assay (SPHA) in syphilis serology. The study focused on detecting IgM antibodies in patients with early or latent syphilis. Researchers wanted to address the issue of IgG interference in IgM testing. The motivation came from the limitations of current fluorescence-based assays. The team sought a simpler and more reliable alternative to FTA-ABS. They tested SPHA alongside existing methods like VDRL and AMHA-TP. The goal was to assess SPHA's accuracy and ease of use in routine diagnostics. The study aimed to determine if SPHA could replace or complement IgM-FTA-ABS.

The study used 63,019 sera samples collected in a routine diagnostic setting. Samples were first screened with VDRL and AMHA-TP tests. Reactive samples underwent further testing with FTA-ABS and IgM-FTA-ABS. A subset was analyzed using the 19S IgM-FTA-ABS test after gelfiltration. The IgM-SPHA test was also applied to these samples. Researchers compared SPHA results with fluorescence-based methods. The study assessed agreement rates between SPHA and 19S IgM-FTA-ABS. The team evaluated SPHA's performance in early and neurosyphilis cases.

The IgM-SPHA test showed high agreement with the 19S IgM-FTA-ABS test, exceeding 96.3%. SPHA detected IgM antibodies in early-stage syphilis cases. The method also identified IgM in patients with active neurosyphilis. It successfully detected IgM in 26 reinfection cases. SPHA eliminated false negatives caused by IgG interference. The test outperformed standard IgM-FTA-ABS in accuracy. Results were consistent across different patient groups. SPHA proved simpler and more automated than fluorescence-based tests.

The SPHA method offers a reliable alternative to IgM-FTA-ABS testing. It eliminates IgG interference that affects fluorescence-based assays. The method shows high agreement with the 19S IgM-FTA-ABS test. SPHA is suitable for early and neurosyphilis detection. The authors propose that SPHA can replace or complement existing methods. The test is simpler and easier to automate than fluorescence techniques. These findings suggest SPHA could improve diagnostic accuracy. The study supports further evaluation of SPHA in routine practice.